medigraphic.com
ISSN 1561-3046 (Electronic)

2014, Number 4

<< Back Next >>

Rev Cub Med Mil 2014; 43 (4)

Influence of the metabolic syndrome on the progress of patients admitted to the Internal Medicine wards

González SO, Arpa GÁ, Hernández SY

Language: Spanish
References: 25
Page: 449-458
PDF size: 124.08 Kb.


ABSTRACT

Introduction: the metabolic syndrome is related to several clinical disturbances and may cause complications hindering the recovery at hospital of patients with this disease.
Objective: to determine the influence of the metabolic syndrome on the recovery of patients admitted to the internal medicine wards.
Methods: cohort study performed from September 2011 through September 2012. The study group comprised 51 patients with the syndrome and 51 patients without this disease, all of them from the internal medicine wards of "Dr Luis Diaz Soto" central military hospital. The study measured demographic, clinical and humoral variables in addition to length of stay at hospital, complications during the hospitalization and the number of drugs used in treatment. The variables from the two groups were then compared through Student's t test and Chi-square test. The relative risk of the syndrome for occurrence of complications was then estimated.
Results: the patients suffering the metabolic syndrome showed a higher number of complications than the control group (37.3 % vs. 9.8 %). The relative risk was 5.46 for 95 % confidence interval (1.8-16.1). The hospital stay of the complicated patients in the study group was 18.2 days, which exceeded that of the noncomplicated cases with 13.1 days (p ‹ 0.05). The group of patients with the metabolic syndrome used 5.1 drugs/patient as average whereas the control group took just 3.3 drugs/patient.
Conclusions: the metabolic syndrome causes more complications, so it requires a higher number of drugs leading to longer stay at hospital.


REFERENCES

  1. Schindhelm RK, Diamant M, Dekker JM. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev. 2006;22:437-43.

  2. Jean-Louis G, Zizi F, Clark LT. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med. 2008;4(3):261-72.

  3. Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol. 2006;169(5):1505-22.

  4. Klaus JR, Hurwitz BE, Llabre MM. Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function. J Cardiometab Syndr. 2009;4:63-71.

  5. Lee JS, Kim SH, Jun DW. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol. 2009;15(15):1869-75.

  6. Dunbar JA, Redy P, Davis-Lameloise N. Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes Care. 2008;31:2368-73.

  7. Pasinetti JM, Eberstein JA. Metabolic syndrome and the role of dietary lifestyles in Alzheimer's disease. J Neurochem. 2008;106(4):1503-14.

  8. Osborn D, Wright CA, Levy G. Relative risk of diabetes, dyslipidemia, hypertension and the metabolic syndrome in people with severe mental illnesss: systematic review and metaanalysis. BMC Psychiatry. 2008;8:84-98.

  9. Tkacova R. Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives. Mediators of Inflammation. 2010;2010:1-14.

  10. Negrón AM, Molina MJ, Mayor AM. Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico. Lupus. 2008;17(4):348-54.

  11. Ninomiya T, Kiyohara Y, Kub M. Metabolic syndrome and chronic kidney disease in a general Japanese population: the Hisayama Study. Am J Kid Diseas. 2006;48(3):383-91.

  12. Hjelmesaeth J, Hifso D, Azsheim ET, et al. Parathyroid hormone but not vitamin D is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovas Diabetol. 2009;8:7-14.

  13. Shantha GPS, Kumar AA, Jeyachandran V. Association between primary hypothyroidism and metabolic syndrome and the role of C reactive protein: a crosssectional study from South India. Thyroid Research. 2009;2:2-9.

  14. Alberti KGMM, Eckel RH, Grundy SM. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5.

  15. Canoy D. Coronary heart disease and body fat distribution. Curr Atheroscler Rep. 2010;12:125-33.

  16. Zidek W, Naditch-Brulé L, Perlini S. Blood pressure control and components of the metabolic syndrome: the GOOD survey. Cardiovas Diabetol. 2009;8:51.

  17. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-realted mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009 Dec;37(12):3001-9.

  18. Gómez-Huelgas R, Bernal López MR, Villalobos A. Hypertriglyceridemic waist: an alternative to the metabolic syndrome? Results of the IMAP Study (multidisciplinary intervention in primary care). Intern J Obes. 2011;35:292-9.

  19. Wang H, Peng DQ. New insights into the mechamism of low high-density lipoprotein cholesterol in obesity. Lipids in Health Disease. 2011;10:176-209.

  20. Johnson RJ, Lanaspa MA, Gaucher EA. Uric acid: a danger signal from the RNa World that may have a role in the epidemic of obesity, metabolic syndrome and cardiorenal disease: evolutionary considerations. Semin Nephrol. 2011 Sep; 31(5):394-9.

  21. Zhang AH, Bai Q, Lai X. Metabolic syndrome and its components associated with endotelial dysfunction in chronic kidney disease patients. Vascular Health Risk Manag. 2012;8:15-21.

  22. Reaven GM. The metabolic syndrome: requiescar in pace. Clinical Chemistry. 2005;51:931-8.

  23. Patel AY, Shah P, Flaherty JH. Number of medications is associated with outcomes in the elderly patient with metabolic syndrome. J Geriat Cardiol. 2012;9:213-9.

  24. Mozaffarian D, Kamineni A, Prineas RJ. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med. 2008;168:969-78.

  25. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119:812-9.




2020     |     www.medigraphic.com